BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Shao C, Tan ML, Mu D, Ferris RL, Ha PK. Molecular biology of adenoid cystic carcinoma. Head Neck 2012;34:1665-77. [PMID: 22006498 DOI: 10.1002/hed.21849] [Cited by in Crossref: 49] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang MJ, Wu CC, Wang S, Yang LL, Sun ZJ. Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma. Oral Dis 2023;29:175-87. [PMID: 34651389 DOI: 10.1111/odi.14045] [Reference Citation Analysis]
2 Alsarraj M, Alshehri SM, Qattan A, Mofti A, Wazqer L, Bukhari S, Shamsaldin A, Rajab R. Lymph Node Involvement and the Clinical Stage as Predictors of the Survival of Patients With Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review and Meta-Analysis. Cureus 2022. [DOI: 10.7759/cureus.30780] [Reference Citation Analysis]
3 Doan C, Aouizerat BE, Ye Y, Dang D, Asam K, Bhattacharya A, Howard T, Patel YK, Viet DT, Figueroa JD, Zhong JF, Thomas CM, Morlandt AB, Yu G, Callahan NF, Allen CT, Grandhi A, Herford AS, Walker PC, Nguyen K, Kidd SC, Lee SC, Inman JC, Slater JM, Viet CT. Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral Cancer. Advanced Biology 2022;6:2200190. [DOI: 10.1002/adbi.202200190] [Reference Citation Analysis]
4 Patel T, Anandani G. Adenoid Cystic Carcinoma of Larynx. Laryngology [Working Title] 2022. [DOI: 10.5772/intechopen.104211] [Reference Citation Analysis]
5 Zhang MJ, Wang S, Wu CC, Wu L, Sun ZJ. Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma. J Oral Pathol Med 2022;51:379-87. [PMID: 35226778 DOI: 10.1111/jop.13289] [Reference Citation Analysis]
6 Todd R. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology 2021. [DOI: 10.1002/9781119730248.ch9] [Reference Citation Analysis]
7 Chami R. Pediatric Surgical Pathology of the Salivary Gland. Pediatric Head and Neck Textbook 2021. [DOI: 10.1007/978-3-030-59265-3_17] [Reference Citation Analysis]
8 Porcheri C, Meisel CT, Mitsiadis TA. Molecular and Cellular Modelling of Salivary Gland Tumors Open New Landscapes in Diagnosis and Treatment. Cancers (Basel) 2020;12:E3107. [PMID: 33114321 DOI: 10.3390/cancers12113107] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
9 Wang S, Yu Y, Fang Y, Huang H, Wu D, Fang H, Bai Y, Sun C, Yu A, Fan Q, Yu Z, Zhang C, Wang C, Tai Z, Huang Y, Li N. Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma in the Chinese population. J Genet Genomics 2020;47:397-401. [PMID: 33077413 DOI: 10.1016/j.jgg.2020.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Hou H, Jia D, Yan W, Zhang X, Wang C, Li Y, Chen H, Huang W, Li Z, Zhang X. KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors. Transl Cancer Res 2020;9:4703-14. [PMID: 35117834 DOI: 10.21037/tcr-20-637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Wu C, Li H, Xiao Y, Deng W, Sun Z. Expression levels of SIX1, ME2, and AP2M1 in adenoid cystic carcinoma and mucoepidermoid carcinoma. Oral Dis 2020;26:1687-95. [DOI: 10.1111/odi.13506] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Wu Q, Sun W, Bu J, Xiang Y, Zhong Y. Primary Adenoid Cystic Carcinoma of the Upper Anterior Mediastinum Mimicking a Thyroid Tumor: A Case Report and Review of Literature. Front Endocrinol (Lausanne) 2020;11:242. [PMID: 32390945 DOI: 10.3389/fendo.2020.00242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Dos Santos ES, Ramos JC, Normando AGC, Mariano FV, Paes Leme AF. Epigenetic alterations in salivary gland tumors. Oral Dis 2020;26:1610-8. [PMID: 31829479 DOI: 10.1111/odi.13253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
14 Li C, Chen Q, Tian Z, Li S, Gong Z, Lin Z, Wang B, Liu H. Expression of MIF, Beclin1, and LC3 in human salivary gland adenoid cystic carcinoma and its prognostic value. Medicine (Baltimore) 2019;98:e15402. [PMID: 31096436 DOI: 10.1097/MD.0000000000015402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Xu LH, Zhao F, Yang WW, Chen CW, Du ZH, Fu M, Ge XY, Li SL. MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma. Int J Oncol 2019;54:1579-90. [PMID: 30896785 DOI: 10.3892/ijo.2019.4754] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
16 Liu X, Chen D, Lao X, Liang Y. The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta‐analysis. Head & Neck 2019;41:1517-24. [DOI: 10.1002/hed.25597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Cao Y, Liu H, Xia SL, Zhang X, Bai H, Yang Q, Li J, Gao L, Jin F, Wei MJ, Lu SL, Xiao J. PTEN downregulates WD repeat‑containing protein 66 in salivary adenoid cystic carcinoma. Oncol Rep 2019;41:1827-36. [PMID: 30569117 DOI: 10.3892/or.2018.6931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Dongsoo K, Chen J, Wei E, Ansari J, Meram A, Patel S, Ghali G, Kevil C, Shackelford RE. Hydrogen Sulfide and Hydrogen Sulfide-Synthesizing Enzymes Are Altered in a Case of Oral Adenoid Cystic Carcinoma. Case Rep Oncol 2018;11:585-90. [PMID: 30283315 DOI: 10.1159/000492464] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Cai WY, Zhuang Y, Yan F, Li T, Song WT, Sun JH. Effect of survivin downregulation by simvastatin on the growth and invasion of salivary adenoid cystic carcinoma. Mol Med Rep 2018;18:1939-46. [PMID: 29956779 DOI: 10.3892/mmr.2018.9204] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Maziak DE. Biology of Adenoid Cystic Carcinoma of the Tracheobronchial Tree and Principles of Management. Thoracic Surgery Clinics 2018;28:145-8. [DOI: 10.1016/j.thorsurg.2018.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
21 Chahal M, Pleasance E, Grewal J, Zhao E, Ng T, Chapman E, Jones MR, Shen Y, Mungall KL, Bonakdar M, Taylor GA, Ma Y, Mungall AJ, Moore RA, Lim H, Renouf D, Yip S, Jones SJM, Marra MA, Laskin J. Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making. Cold Spring Harb Mol Case Stud 2018;4:a002626. [PMID: 29610392 DOI: 10.1101/mcs.a002626] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
22 Zhu X, Yu Y, Hou X, Xu J, Tan Z, Nie X, Ling Z, Ge M. Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis. Oncol Lett 2018;15:1149-56. [PMID: 29399171 DOI: 10.3892/ol.2017.7408] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Hu XM, Lin T, Huang XY, Gan RH, Zhao Y, Feng Y, Ding LC, Su BH, Zheng DL, Lu YG. ID1 contributes to cell growth invasion and migration in salivary adenoid cystic carcinoma. Mol Med Rep 2017;16:8907-15. [PMID: 29039489 DOI: 10.3892/mmr.2017.7744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
24 Hazkani I, Motiei M, Betzer O, Sadan T, Bragilovski D, Lubimov L, Mizrachi A, Hadar T, Levi M, Ben-Aharon I, Haviv I, Popovtzer R, Popovtzer A. Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma. Theranostics 2017;7:3962-71. [PMID: 29109791 DOI: 10.7150/thno.19615] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
25 Li J, Gao H, Meng L, Yin L. Mithramycin inhibits epithelial-to-mesenchymal transition and invasion by downregulating SP1 and SNAI1 in salivary adenoid cystic carcinoma. Tumour Biol 2017;39:1010428317708697. [PMID: 28631560 DOI: 10.1177/1010428317708697] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
26 Thakrar DB, Cho WS, Bishop F. A case of palatal adenoid cystic carcinoma with late recurrence. BJGP Open 2017;1:bjgpopen17X100785. [PMID: 30564658 DOI: 10.3399/bjgpopen17X100785] [Reference Citation Analysis]
27 de Souza LB, de Oliveira LC, Nonaka CFW, Lopes MLDS, Pinto LP, Queiroz LMG. Immunoexpression of GLUT-1 and angiogenic index in pleomorphic adenomas, adenoid cystic carcinomas, and mucoepidermoid carcinomas of the salivary glands. Eur Arch Otorhinolaryngol 2017;274:2549-56. [PMID: 28299426 DOI: 10.1007/s00405-017-4530-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ouyang D, Liang L, Ke Z, Zheng G, Weng D, Yang W, Su Y, Liao G. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma: AKT and mTOR expression in adenoid cystic carcinoma. Head Neck 2017;39:1145-54. [DOI: 10.1002/hed.24732] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
29 Kim Y, Lee SJ, Lee JY, Lee SH, Sun JM, Park K, An HJ, Cho JY, Kang EJ, Lee HY, Kim J, Keam B, Kim HR, Lee KE, Choi MY, Lee KH, Ahn MJ. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01). Cancer 2017;123:1958-64. [PMID: 28102887 DOI: 10.1002/cncr.30537] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
30 Garber ST, Khoury L, Bell D, Schomer DF, Janku F, Mccutcheon IE. Metastatic Adenoid Cystic Carcinoma Mimicking Butterfly Glioblastoma: A Rare Presentation in the Splenium of the Corpus Callosum. World Neurosurgery 2016;95:621.e13-9. [DOI: 10.1016/j.wneu.2016.07.111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Prakash S, Swaminathan U, Nagamalini BR, Krishnamurthy AB. Beta-catenin in disease. J Oral Maxillofac Pathol 2016;20:289-99. [PMID: 27601825 DOI: 10.4103/0973-029X.185938] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
32 Sridharan V, Gjini E, Liao X, Chau NG, Haddad RI, Severgnini M, Hammerman P, El-Naggar A, Freeman GJ, Hodi FS, Rodig SJ, Dranoff G, Schoenfeld JD. Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. Cancer Immunol Res 2016;4:679-87. [PMID: 27312343 DOI: 10.1158/2326-6066.CIR-16-0031] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
33 Jiang Y, Feng X, Zheng L, Li SL, Ge XY, Zhang JG. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma. Oncotarget 2015;6:25506-19. [PMID: 26325518 DOI: 10.18632/oncotarget.4635] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
34 Zhao L, Jiang L, Du P, Zhang D, Liu Z, Li K, Zhang B. Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis. Acta Otolaryngol 2016;136:575-9. [PMID: 26881872 DOI: 10.3109/00016489.2016.1142117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
35 Ling S, Rettig EM, Tan M, Chang X, Wang Z, Brait M, Bishop JA, Fertig EJ, Considine M, Wick MJ, Ha PK. Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening. Int J Oncol 2016;49:225-34. [PMID: 27212063 DOI: 10.3892/ijo.2016.3532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Liu H, Du L, Wang R, Wei C, Liu B, Zhu L, Liu P, Liu Q, Li J, Lu SL, Xiao J. High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy. Oncotarget 2015;6:11477-91. [PMID: 25909167 DOI: 10.18632/oncotarget.3411] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
37 Yin LX, Ha PK. Genetic alterations in salivary gland cancers. Cancer 2016;122:1822-31. [PMID: 26928905 DOI: 10.1002/cncr.29890] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
38 Rettig EM, Talbot CC Jr, Sausen M, Jones S, Bishop JA, Wood LD, Tokheim C, Niknafs N, Karchin R, Fertig EJ, Wheelan SJ, Marchionni L, Considine M, Ling S, Fakhry C, Papadopoulos N, Kinzler KW, Vogelstein B, Ha PK, Agrawal N. Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma. Cancer Prev Res (Phila) 2016;9:265-74. [PMID: 26862087 DOI: 10.1158/1940-6207.CAPR-15-0316] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
39 Qu J, Song M, Xie J, Huang XY, Hu XM, Gan RH, Zhao Y, Lin LS, Chen J, Lin X, Zheng DL, Lu YG. Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma. Mol Cell Biochem 2016;411:135-41. [PMID: 26427670 DOI: 10.1007/s11010-015-2575-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
40 Jiang LH, Ge MH, Hou XX, Cao J, Hu SS, Lu XX, Han J, Wu YC, Liu X, Zhu X, Hong LL, Li P, Ling ZQ. miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma. Lab Invest 2015;95:1398-408. [PMID: 26367487 DOI: 10.1038/labinvest.2015.105] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
41 Todd R. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology 2015. [DOI: 10.1002/9781118949139.ch8] [Reference Citation Analysis]
42 Park S, Nam SJ, Keam B, Kim TM, Jeon YK, Lee SH, Hah JH, Kwon TK, Kim DW, Sung MW, Heo DS, Bang YJ. VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma. Cancer Res Treat 2016;48:518-26. [PMID: 26194375 DOI: 10.4143/crt.2015.093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
43 Hsu AA, Tan EH, Takano AM. Lower Respiratory Tract Adenoid Cystic Carcinoma: Its Management in the Past Decades. Clin Oncol (R Coll Radiol) 2015;27:732-40. [PMID: 26160258 DOI: 10.1016/j.clon.2015.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
44 Rettig EM, Tan M, Ling S, Yonescu R, Bishop JA, Fakhry C, Ha PK. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma. Laryngoscope 2015;125:E292-9. [PMID: 25963073 DOI: 10.1002/lary.25356] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
45 Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A, Haigentz M Jr, Takes RP, Mondin V, Teymoortash A, Thompson LD, Ferlito A. Adenoid cystic carcinoma of the head and neck--An update. Oral Oncol 2015;51:652-61. [PMID: 25943783 DOI: 10.1016/j.oraloncology.2015.04.005] [Cited by in Crossref: 249] [Cited by in F6Publishing: 267] [Article Influence: 31.1] [Reference Citation Analysis]
46 Sun X. Thyroid Gland, Salivary Gland, and Thymus. Well-Differentiated Malignancies 2015. [DOI: 10.1007/978-1-4939-1692-4_9] [Reference Citation Analysis]
47 Etori F, Watanabe N, Matsuyama M, Kawaguchi N, Sekiya A, Nambu K, Sakakima T, Sawa T, Marui T, Naiki T, Tanaka T. Primary adenoid cystic carcinoma in the peripheral lung: a cytological, histopathological and immunohistochemical report of two cases. Pathol Discov 2015;3:3. [DOI: 10.7243/2052-7896-3-3] [Reference Citation Analysis]
48 Zhu X, Xu JJ, Hu SS, Feng JG, Jiang LH, Hou XX, Cao J, Han J, Ling ZQ, Ge MH. Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma. J Exp Clin Cancer Res 2014;33:114. [PMID: 25551195 DOI: 10.1186/s13046-014-0114-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
49 Phuchareon J, Overdevest JB, McCormick F, Eisele DW, van Zante A, Tetsu O. Fatty Acid binding protein 7 is a molecular marker in adenoid cystic carcinoma of the salivary glands: implications for clinical significance. Transl Oncol 2014;7:780-7. [PMID: 25500088 DOI: 10.1016/j.tranon.2014.10.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
50 Phuchareon J, van Zante A, Overdevest JB, McCormick F, Eisele DW, Tetsu O. c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands. Transl Oncol 2014;7:537-45. [PMID: 25389449 DOI: 10.1016/j.tranon.2014.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
51 O’connor R, Mitchell DA, Brennan PA. Focused review of investigation, management and outcomes of salivary gland disease in specialty-specific journals. British Journal of Oral and Maxillofacial Surgery 2014;52:483-90. [DOI: 10.1016/j.bjoms.2014.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
52 Thomson DJ, Silva P, Denton K, Bonington S, Mak SK, Swindell R, Homer J, Sykes AJ, Lee LW, Yap BK, Slevin NJ. Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck: Phase II trial of sorafenib in advanced adenoid cystic carcinoma. Head Neck 2015;37:182-7. [DOI: 10.1002/hed.23577] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
53 Ross JS, Wang K, Rand JV, Sheehan CE, Jennings TA, Al-Rohil RN, Otto GA, Curran JC, Palmer G, Downing SR. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies. Am J Surg Pathol. 2014;38:235-238. [PMID: 24418857 DOI: 10.1097/pas.0000000000000102] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
54 Tan M, Shao C, Bishop JA, Feng Z, Trock BJ, Westra WH, Ha PK. Aquaporin-1 promoter hypermethylation is associated with improved prognosis in salivary gland adenoid cystic carcinoma. Otolaryngol Head Neck Surg 2014;150:801-7. [PMID: 24493792 DOI: 10.1177/0194599814521569] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
55 Bell D, Hanna EY. Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment? Current Opinion in Otolaryngology & Head and Neck Surgery 2013;21:124-9. [DOI: 10.1097/moo.0b013e32835c05fd] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
56 Qi C, Shao Y, Li N, Zhang C, Zhao M, Gao F. Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma. Med Oncol 2013;30:491. [PMID: 23389919 DOI: 10.1007/s12032-013-0491-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
57 Sun J, Luo Y, Tian Z, Gu L, Xia SC, Yu Y. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance. BMC Cancer 2012;12:499. [PMID: 23110497 DOI: 10.1186/1471-2407-12-499] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
58 Liu H, Chen G, Zhang W, Zhu J, Lin Z, Gong Z, Wang F, Jia J, Sun Z, Zhao Y. Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol 2013;139:287-95. [DOI: 10.1007/s00432-012-1330-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]